Relationship between urinary angiotensinogen and salt sensitivity of blood pressure in patients with IgA nephropathy

Hypertension

Volumn 58, Issue 2, 2011, Pages 205-211

  Konishi, Yoshio ^a   Nishiyama, Akira ^b   Morikawa, Takashi ^a   Kitabayashi, Chizuko ^a   Shibata, Mikiko ^a   Hamada, Masahiro ^a   Kishida, Masatsugu ^a   Hitomi, Hirofumi ^b   Kiyomoto, Hideyasu ^c   Miyashita, Takenori ^b   Mori, Nozomu ^b   Urushihara, Maki ^c   Kobori, Hiroyuki ^b   Imanishi, Masahito ^a  

^a OSAKA CITY GENERAL HOSPITAL   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Angiotensinogen; glomerulonephritis; hypertension; IgA nephropathy; renin angiotensin system; salt

Indexed keywords

ALDOSTERONE; ANGIOTENSINOGEN; CREATININE;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; CHEMOSENSITIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; CREATININE URINE LEVEL; DISEASE ASSOCIATION; EXPLORATORY RESEARCH; FEMALE; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; INTERSTITIAL NEPHRITIS; KIDNEY BLOOD FLOW; MALE; MEAN ARTERIAL PRESSURE; NATRIURESIS; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RETROSPECTIVE STUDY; SALT SENSITIVITY; SODIUM EXCRETION; SODIUM RESTRICTION; URINARY EXCRETION;

ADULT; ANGIOTENSINOGEN; BLOOD PRESSURE; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY; MALE; MIDDLE AGED; RENIN-ANGIOTENSIN SYSTEM; RETROSPECTIVE STUDIES; SODIUM CHLORIDE, DIETARY;

EID: 80051469912     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.166843     Document Type: Article

References (37)

1. Kimura G, Frem GJ, Brenner BM. Renal mechanisms of salt sensitivity in hypertension. Curr Opin Nephrol Hypertens. 1994;3:1-12.
2. Morimoto A, Uzu T, Fujii T, Nishimura M, Kuroda S, Nakamura S, Inenaga T, Kimura G. Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet. 1997;350:1734-1737. (Pubitemid 28036672)
3. Weinberger MH, Fineberg NS, Fineberg SE, Weinberger M. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension. 2001;37:429-432. (Pubitemid 32199006)
4. Konishi Y, Okada N, Okamura M, Morikawa T, Okumura M, Yoshioka K, Imanishi M. Sodium sensitivity of blood pressure appearing before hypertension and related to histological damage in immunoglobulin A nephropathy. Hypertension. 2001;38:81-85. (Pubitemid 34224775)
5. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal reninangiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 2007;59:251-287. (Pubitemid 47481436)
6. Silva GB, Garvin JL. Angiotensin II-dependent hypertension increases na transport-related oxygen consumption by the thick ascending limb. Hypertension. 2008;52:1091-1098.
7. Nishiyama A, Yoshizumi M, Rahman M, Kobori H, Seth DM, Miyatake A, Zhang GX, Yao L, Hitomi H, Shokoji T, Kiyomoto H, Kimura S, Tamaki T, Kohno M, Abe Y. Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in dahl salt-sensitive rats. Kidney Int. 2004;65:972-981. (Pubitemid 38251073)
8. Tojo A, Onozato ML, Kobayashi N, Goto A, Matsuoka H, Fujita T. Antioxidative effect of p38 mitogen-activated protein kinase inhibitor in the kidney of hypertensive rat. J Hypertens. 2005;23:165-174. (Pubitemid 40128995)
9. Bayorh MA, Ganafa AA, Emmett N, Socci RR, Eatman D, Fridie IL. Alterations in aldosterone and angiotensin II levels in salt-induced hypertension. Clin Exp Hypertens. 2005;27:355-367. (Pubitemid 40686601)
10. Franco M, Martinez F, Quiroz Y, Galicia O, Bautista R, Johnson RJ, Rodriguez-Iturbe B. Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol. 2007;293:R251-R256. (Pubitemid 47096573)
11. Kobori H, Nishiyama A, Abe Y, Navar LG. Enhancement of intrarenal angiotensinogen in dahl salt-sensitive rats on high salt diet. Hypertension. 2003;41:592-597. (Pubitemid 36314637)
12. Kobori H, Nishiyama A. Effects of tempol on renal angiotensinogen production in dahl salt-sensitive rats. Biochem Biophys Res Commun. 2004;315:746-750. (Pubitemid 38229405)
13. Katsurada A, Hagiwara Y, Miyashita K, Satou R, Miyata K, Ohashi N, Navar LG, Kobori H. Novel sandwich ELISA for human angiotensinogen. Am J Physiol Renal Physiol. 2007;293:F956-F960. (Pubitemid 47403368)
14. Suzaki Y, Ozawa Y, Kobori H. Quantification of human angiotensinogen by a novel sandwich ELISA. Peptides. 2006;27:3000-3002. (Pubitemid 44584393)
15. Nishiyama A, Konishi Y, Ohashi N, Morikawa T, Urushihara M, Maeda I, Hamada M, Kishida M, Hitomi H, Shirahashi N, Kobori H, Imanishi M. Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy. Nephrol Dial Transplant. 2011;26:170-177.
16. Konishi Y, Morikawa T, Yasu T, Teramoto K, Okada N, Yoshioka K, Okumura M, Imanishi M. Blunted response of the renin-angiotensin system and nitric oxide synthesis related to sodium sensitivity in immunoglobulin A nephropathy. Hypertens Res. 2004;27:7-13. (Pubitemid 38208416)
17. Devaiah AK, Ator GA. Clinical indicators useful in predicting response to the medical management of meniere's disease. Laryngoscope. 2000;110: 1861-1865.
18. Santos PM, Hall RA, Snyder JM, Hughes LF, Dobie RA. Diuretic and diet effect on Meniere's disease evaluated by the 1985 committee on hearing and equilibrium guidelines. Otolaryngol Head Neck Surg. 1993; 109:680-689. (Pubitemid 23335967)
19. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Committee on Hearing and Equilibrium Guidelines for the Diagnosis and Evaluation of Therapy in Meniere's Disease. Otolaryngol Head Neck Surg. 1995;113:181-185.
20. Kobori H, Nishiyama A, Harrison-Bernard LM, Navar LG. Urinary angiotensinogen as an indicator of intrarenal angiotensin status in hypertension. Hypertension. 2003;41:42-49. (Pubitemid 36056790)
21. Kobori H, Harrison-Bernard LM, Navar LG. Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int. 2002;61:579-585. (Pubitemid 34102599)
22. Kobori H, Ohashi N, Katsurada A, Miyata K, Satou R, Saito T, Yamamoto T. Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases. J Am Soc Hypertens. 2008;2: 349-354.
23. Kobori H, Alper AB Jr, Shenava R, Katsurada A, Saito T, Ohashi N, Urushihara M, Miyata K, Satou R, Hamm LL, Navar LG. Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients. Hypertension. 2009;53:344-350.
24. Yamamoto T, Nakagawa T, Suzuki H, Ohashi N, Fukasawa H, Fujigaki Y, Kato A, Nakamura Y, Suzuki F, Hishida A. Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease. J Am Soc Nephrol. 2007;18:1558-1565. (Pubitemid 46717523)
25. Kaplan N. Primary hypertension: pathogenesis. In: Kaplan N, ed. Kaplan's Clinical Hypertension. Philadelphia, PA: Lippincott Williams and Wilkins; 2006:50-121.
26. Fukuda M, Yamanaka T, Mizuno M, Motokawa M, Shirasawa Y, Miyagi S, Nishio T, Yoshida A, Kimura G. Angiotensin II type 1 receptor blocker, olmesartan, restores nocturnal blood pressure decline by enhancing daytime natriuresis. J Hypertens. 2008;26:583-588. (Pubitemid 351317269)
27. Cianciaruso B, Bellizzi V, Minutolo R, Colucci G, Bisesti V, Russo D, Conte G, De Nicola L. Renal adaptation to dietary sodium restriction in moderate renal failure resulting from chronic glomerular disease. J Am Soc Nephrol. 1996;7:306-313. (Pubitemid 26092480)
28. Chan LY, Leung JC, Tang SC, Choy CB, Lai KN. Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy. J Am Soc Nephrol. 2005;16:2306-2317. (Pubitemid 41725048)
29. Ohashi N, Katsurada A, Miyata K, Satou R, Saito T, Urushihara M, Kobori H. Role of activated intrarenal reactive oxygen species and reninangiotensin system in IgA nephropathy model mice. Clin Exp Pharmacol Physiol. 2009;36:750-755.
30. Kobori H, Katsurada A, Ozawa Y, Satou R, Miyata K, Hase N, Suzaki Y, Shoji T. Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients. Biochem Biophys Res Commun. 2007;358:156-163. (Pubitemid 46719097)
31. Urushihara M, Kondo S, Kagami S, Kobori H. Urinary angiotensinogen accurately reflects intrarenal renin-angiotensin system activity. Am J Nephrol. 31:318-325.
32. Yanes LL, Sartori-Valinotti JC, Iliescu R, Romero DG, Racusen LC, Zhang H, Reckelhoff JF. Testosterone-dependent hypertension and upregulation of intrarenal angiotensinogen in Dahl salt-sensitive rats. Am J Physiol Renal Physiol. 2009;296:F771-F779.
33. Gould AB, Green D. Kinetics of the human renin and human substrate reaction. Cardiovasc Res. 1971;5:86-89.
34. Brasier AR, Li J. Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension. 1996;27:465-475. (Pubitemid 26086217)
35. Ohashi N, Katsurada A, Miyata K, Satou R, Saito T, Urushihara M, Kobori H. Activation of reactive oxygen species and the renin-angiotensin system in iga nephropathy model mice. Clin Exp Pharmacol Physiol. 2009;36:509-515.
36. Zhou A, Carrell RW, Murphy MP, Wei Z, Yan Y, Stanley PL, Stein PE, Broughton Pipkin F, Read RJ. A redox switch in angiotensinogen modulates angiotensin release. Nature. 2010;468:108-111.
37. Saito T, Urushihara M, Kotani Y, Kagami S, Kobori H. Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetes. Am J Med Sci. 2009;338:478-480.